Icure Pharmaceutical Incorporation (KOSDAQ:175250)

South Korea · Delayed Price · Currency is KRW

2,110.00

0.00 (0.00%)

At close: Sep 3, 2026

KOSDAQ:175250 Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	114,425	83,385	50,705	56,806	59,367	64,283
Revenue Growth	101.68%	64.45%	-10.74%	-4.31%	-7.65%	-28.69%
Gross Profit	8,991	4,398	6,641	1,298	-5,580	-4,804
Operating Income	-10,202	-18,333	-15,969	-27,605	-27,087	-30,119
Net Income	-21,682	-33,600	1,198	-31,272	-41,766	-38,167
Earnings Per Share	-578.39	-897.45	32.00	-837.00	-1793.00	-1763.00
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	8,166	11,010	22,437	8,558	53,786	24,417
Total Debt	25,200	27,655	40,440	74,015	87,009	74,186
Net Cash (Debt)	-17,034	-16,645	-18,003	-65,457	-33,224	-49,769
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-454.39	-444.58	-481.04	-1742.81	-1426.23	-2298.37

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-2,340	-2,685	-17,054	-13,519	-11,282	-26,228
Capital Expenditures	-3,886	-5,110	-2,023	-2,225	-4,197	-5,701
Free Cash Flow	-6,226	-7,795	-19,077	-15,744	-15,479	-31,929
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	7.86%	5.27%	13.10%	2.28%	-9.40%	-7.47%
Operating Margin	-8.92%	-21.99%	-31.49%	-48.59%	-45.63%	-46.85%
Pretax Margin	-20.69%	-42.34%	6.89%	-57.00%	-72.58%	-60.41%
Profit Margin	-18.95%	-40.29%	2.36%	-55.05%	-70.35%	-59.37%
FCF Margin	-5.44%	-9.35%	-37.62%	-27.72%	-26.07%	-49.67%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	56.63	-	-	-
Forward PE	-	7.87	7.87	7.87	7.87	7.87
PS Ratio	0.69	0.97	1.34	1.38	1.34	5.27